Introduction
============

The development and growth of the temporomandibular joint (TMJ) have long been recognized as different from that of long bone joints [@B1], [@B2]. However, whether these cartilages with different developmental histories and structures also differ in their genetic regulation has only begun to be investigated in the last decade [@B3]. We have shown that deletion of *Bmpr1a*, a primary receptor for BMP-2 and BMP-4, in growth plate [@B4] and mandibular condylar cartilage (MCC) chondrocytes [@B5] not only leads to defects in chondrogenesis, but also in osteogenesis. These results support the new concept recently demonstrated by our lab and others that chondrocytes directly transform in considerable numbers into bone cells, thus making them the primary progenitor cells for endochondral bone formation rather than in-migrating cells from either bone marrow or periosteum [@B6]-[@B11]. In the growth plate, *Bmpr1a* null mice demonstrate a virtual cessation of endochondral bone formation [@B4] while in MCC of the same *Bmpr1a* null mice the subchondral bone phenotype is completely different [@B5]. This indicates that there may be diverse mechanisms for the same receptor in different skeletal locations (i.e., MCC vs growth plate) or that other regulators of chondrogenesis might affect MCC growth in unique ways.

Signaling via the Wnt/β-catenin pathway is a well-established regulator of skeletal development and growth including growth plate and articular cartilage [@B12]-[@B20]. Cartilage-derived *β-catenin* is a central mediator for major events during endochondral bone formation, including chondrogenesis, primary and secondary ossification center development, vascularization, and perichondrial bone formation [@B14]. Moreover, β-catenin signaling is required for determining osteoblast versus chondrocyte cell fate and promoting chondrocyte proliferation and maturation [@B20]. In vivo mouse genetic studies using a constituently active form of *β-catenin* under the control of a Col2 promoter demonstrated that the growth plate in postnatal mice undergoes closure within weeks of tamoxifen (TM) activation of the transgene [@B21]. β-catenin signaling in chondrocytes also plays a key role in the postnatal bone growth and bone remodeling likely through its regulation of osteoclast formation [@B22].

Most studies have focused on limb cartilages, with little attention to cartilages in the craniofacial region. Mice lacking Wnt/β-catenin or with constitutive activation of Wnt/β-catenin have been shown to exhibit disrupted growth in the cranial base synchondroses [@B23], but these are primary cartilages with developmental affinities to limb growth plate. The role of β-catenin signaling during TMJ development and growth has been little studied, with only two very different studies comprising our knowledge base; a developmental study showing agenesis of the MCC in mice with stabilization of *β-catenin* [@B24] and osteoarthritic changes in mice with conditional activation of*β-catenin* in MCC chondrocytes [@B25].

In this study, we employed recent advances in cell lineage tracing technology to investigate the role of β-catenin signaling in the regulation of condylar growth. Using the background of *R26R*^Tomato^, we demonstrated an essential role for *β-catenin* in the cell transformation of chondrocytes into bone cells (osteoblasts/osteocytes) by employing chondrocyte-specific *β-catenin* loss-of-function models (using the *β-catenin^fx/fx^ line* crossed to either the *Aggrecan*-Cre^ERT2^ or *Col10a1*-Cre line) and gain-of-function genetic mouse models (using the tamoxifen-inducible *Aggrecan*-Cre^ERT2^).

Materials and Methods
=====================

Breeding transgenic mice
------------------------

To generate triple mice to conditionally knockout *β-catenin* in all chondrocytes or specifically in hypertrophic chondrocytes, β-catenin^flox^ [@B26], and *R26R*^Tomato^ (B6;129S6-*Gt(ROSA)26Sor^tm9(CAG-tdTomato)Hze^*/J, stock number: 007905 from the Jackson Laboratory) were internally crossed with *Aggrecan* (*Acan*)-Cre^ERT2^ (one-time tamoxifen injection at day 3, i.p.) [@B27] or *Col10a1-*Cre mice [@B28], respectively. Similarly, to generate triple mice for studies of the fate of chondrocytes with constitutively active *β-catenin* in chondrocytes (CA-β-cat) [@B29], *Acan*-Cre^ERT2^ (one-time tamoxifen injection at day 3 or 14, i.p.), *β*-catenin*^flox(Ex3)/flox(Ex3)^*, and *R26R*^Tomato^ were internally crossed three times. Tamoxifen (Sigma, T5648) was dissolved in 90% corn oil (Sigma, C8267) and 10% ethanol. Four animals were used in either control or mutant group at each time point.

All protocols were reviewed and approved by the Institutional Animal Care and Use Committee (IACUC) at Texas A&M University College of Dentistry.

Histological analysis
---------------------

Mandibular condyles were fixed in 4% paraformaldehyde and decalcified at 4 °C. Samples for cell lineage tracing were dehydrated with sucrose and embedded in OCT followed by CryoJane frozen sections as previously described [@B30]. Samples for histological staining were embedded in paraffin, sectioned, and stained with safranin O (proteoglycans) or toluidine blue stain [@B31]. Immunostaining were proceeded as previously described [@B32] with the following antibodies: rabbit anti-aggrecan antibody (Abcam; 1:400), anti-collagen II mouse monoclonal antibody (Santa Cruz Biotechnology; 1:50), rabbit anti-collagen X antibody (Abcam; 1:400), rabbit anti-DMP1 antibody (provided by Dr. Chunlin Qin at Texas A&M University, 1:400), rabbit anti-Runx2 antibody (Abcam; 1:200), goat anti-sclerostin antibody (R&D; 1:400), rabbit anti-collagen I antibody (Abcam; 1:100), anti-osteopontin mouse monoclonal antibody (Santa Cruz Biotechnology; 1:100), or anti-β-catenin mouse monoclonal antibody (DSHB; 1:100). The immunohistochemistry experiments were detected with a 3, 3-diaminobenzidine kit (Vector Laboratories, Burlingame, CA). The immunofluorescent signals were detected with corresponding Alexa second antibody (Thermofisher, 1:200) at room temperature for 2 hours.

Cell proliferation
------------------

BrdU (Sigma, 10 mg/ml) or EdU (Life technique, 10mg/ml) was injected into mice (two times for BrdU: 24- and 2 hours before sacrifice, i.p.; one time for EdU, 2 hours before sacrifice, i.p.). Image J was used to quantify the BrdU^+^ or EdU^+^ cells in MCC proliferating layers [@B5].

Confocal microscopy
-------------------

SP5 Leica confocal microscope was used to capture the fluorescent cell images. All images were obtained at wavelengths ranging from 488 (green)-561 (red) μm. Multiple stacked images were taken at 100Hz and dimension of 1024x1024 [@B33]. Red color reflected by tomato signal indicated the descendant cells with Cre-activity; green color represented the corresponding immunofluorescent staining; blue color was DAPI staining.

Radiographs
-----------

The mandibles were dissected free of muscles and were taken X-ray by using a Faxitron model MX-20 Specimen Radiography System (Faxitron X-Ray Corp., Lincolnshire, IL, USA). The mandibular length was measured from the middle of the condylar head curvature to the most anterior point on the incisal alveolar process, and quantified by Image J software (Figure [S2](#SM0){ref-type="supplementary-material"}A) [@B5].

Backscattered scanning electron microscopy (SEM), acid-etched SEM
-----------------------------------------------------------------

The mandibles were fixed in 4% paraformaldehyde, dehydrated in ascending concentrations of ethanol (from 70% to 100%), and embedded in methyl-methacrylate (MMA, Buehler, Lake Bluff, IL) [@B34], which were cut and polished by using 1 μm and 0.3 μm alumina alpha micropolish II solution (Buehler). For acid etched SEM, samples were treated with 37% phosphoric acid for 2 to 10 seconds, 5% sodium hydrochloride for 5 minutes and then coated with gold (for acid-etched SEM imaging). For backscattered SEM, samples were coated with carbon. FEI/Philips XL30 field-emission environmental SEM (Hillsboro, OR, USA) was used to scan as described previously [@B35].

Statistical Analysis
--------------------

All data were reported as mean (SD). The Kruskal-Wallis test was used to detect the significant differences among samples. The Mann-Whitney U test (post hoc test) was used to compare differences between the mutant and age-matched control groups. Significance level was defined as \*p \< 0.05; \*\*p \< 0.01.

Results
=======

Deleting *β*-catenin in early chondrocytes led to a malformed ramus, defective chondrogenesis, and a lack of trans-differentiation of chondrocytes into bone cells
------------------------------------------------------------------------------------------------------------------------------------------------------------------

To address the impact of loss of β-catenin signaling (a cross of *β-catenin^fx/fx^* and *Acan*-Cre^ERT2^ mice) on MCC and ramus formation, we induced the deletion of *β-catenin* event in the cartilage at P3 and harvested mice at ages of 2-, 4- and 12-weeks. X-ray images displayed a radiolucent area (correlated to the calcified cartilage region) in the 2 week-old condylar head with a low mineral density in the TMJ ramus (Figure [1](#F1){ref-type="fig"}A, *upper right*). By the ages of 4- and 12-weeks, a lack of calcified cartilage in the condylar head, an expanded ramus neck and a sharply reduced ramus length were evident (Figure [1](#F1){ref-type="fig"}A, *middle* and*lower right panels*). Mandibular length was significantly reduced compared to controls at the age of 12-weeks (Figure [1](#F1){ref-type="fig"}B). Toluidine blue-stained sections of 2-week-old cKO condyles showed a reduction in the metachromatic area of the MCC, largely due to the virtual absence of the region of flattened and early chondrocytes (Figure [1](#F1){ref-type="fig"}C). Importantly, there was essentially no trabecular bone present except immediately deep to the MCC in cKO mice. The EdU assay showed a significant reduction in cell proliferation in the prechondroblastic zone of the cKO MCC compared to controls (Figure [1](#F1){ref-type="fig"}D; white arrow).

To trace the cell fate of chondrocytes lacking β-catenin signaling, we generated the above cKO mice in the background of *R26R*^Tomato^ (i.e., deletion of *β-catenin* and activation of red tomato in chondrocytes occurred at 3 days of age and traced the cell fate at 14 days). The confocal images displayed the expected presence of numerous red cells in the subchondral bone, reflecting their initial cell origin as chondrocytes. When combined with green IHC signals, Col2 (Figure [1](#F1){ref-type="fig"}E), Col 10 (Figure [1](#F1){ref-type="fig"}F) or DMP1 (Figure [1](#F1){ref-type="fig"}G; osteocyte marker) were located as expected in the control group (*left panels*). However, in cKO mice, there were few red bone cells in the area deep to the immediate subchondral bone, resulting in an open region within the ramus (Figure [1](#F1){ref-type="fig"}E-G). Furthermore, the extent of immunoreactivity for Col 2 and Col 10 was greatly reduced compared to controls (Figure [1](#F1){ref-type="fig"}E-F). DMP1 signal was greatly reduced in the trabecular bone of cKO mice (Figure [1](#F1){ref-type="fig"}G). In 4-week old cKO mice (induced at day 3), Col 10 expression was largely undetectable (Figure [S1](#SM0){ref-type="supplementary-material"}A). The combined red tomato and green DMP1 images revealed few transformed red bone cells in the subchondral bone area (Figure [S1](#SM0){ref-type="supplementary-material"}B).

Together, the above studies not only confirmed a critical role for β-catenin signaling in MCC chondrogenesis but also revealed a novel role for *β-catenin* in controlling cell trans-differentiation of chondrocytes into bone cells during MCC growth.

Deletion of *β*-*catenin* in hypertrophic chondrocytes (HCs) resulted in diminished endochondral bone formation
---------------------------------------------------------------------------------------------------------------

Although *Acan*-Cre^ERT2^ line is expressed in all chondrocytes, the deletion of *β*-catenin by this Cre mainly reflects the impact of *β-catenin* in early chondrocytes (Figure [1](#F1){ref-type="fig"}). To test the role of *β*-*catenin* in the cell trans-differentiation from HCs into bone cells, we generated a compound mouse line containing *Col10a1*-Cre*, β*-catenin*^fx/fx^*, and *R26R*^Tomato^ and harvested the mice at age of 2 weeks. X-ray images showed an expanded radiolucent area (correlated to the calcified cartilage region) in the 2 week-old condylar head with an extremely low mineral density in the MCC ramus (Figure [2](#F2){ref-type="fig"}A). Toluidine blue-stained sections displayed an expansion of all MCC cartilage layers with a particular increase in the cKO HCs (Figure [2](#F2){ref-type="fig"}B). Similar to the phenotype in *Acan*-Cre^ERT2^; *β-catenin* cKO mice, there was no trabecular bone present (Figure [2](#F2){ref-type="fig"}A-B). Cell lineage studies combined with IHC demonstrated a considerably thickened Col 2^+^ region (Figure [2](#F2){ref-type="fig"}C), as well as a somewhat increased thickness of Col 10^+^ cells (Figure [2](#F2){ref-type="fig"}D) in the cKO mice. In the thin layer of cKO subchondral bone, there were sharp reductions in expression of Runx2 (a marker of preosteoblasts; Figure [2](#F2){ref-type="fig"}E) and two markers of osteocytes: SOST (Figure [2](#F2){ref-type="fig"}F) and DMP1 (Figure [2](#F2){ref-type="fig"}G), indicating an additional role for *β*-*catenin* in the continuing bone cell maturation after the cell trans-differentiation.

Taken together, use of both *Acan*-Cre^ERT2^ and *Col10a1*-Cre loss-of-function models demonstrated that *β-catenin* plays a critical role in MCC proliferation and chondrogenesis and in the trans-differentiation of chondrocytes into bone cells, the major source of bone cells during MCC endochondral bone formation.

Constitutive activation of *β-catenin* in MCC accelerated chondrogenesis and cell trans-differentiation coupled with widespread calcification in the cartilage
--------------------------------------------------------------------------------------------------------------------------------------------------------------

To further address the role of *β-catenin* in MCC growth, we generated a gain-of-function model containing *Acan*-Cre^ERT2^, *β*-catenin*^flox(Ex3)/flox(Ex3)^* and *R26R*^Tomato^ (CA-β-cat mice), and constitutively activated *β-catenin* in chondrocytes for 5 days (one-time tamoxifen injection at day 3 and harvested at day 7); 14 days (one-time tamoxifen injection at 2-week and harvested at 4-week); 5.5 months (one-time tamoxifen injection at 2-week and harvested at 6-month), respectively.

The early activation of *β-catenin* in chondrocytes greatly enhanced chondrogenesis reflected by sharp increases in Col 2 expression (Figure [3](#F3){ref-type="fig"}A), and osteogenesis revealed by increases in Col 1 (Figure [3](#F3){ref-type="fig"}B) and DMP1 expression (Figure [3](#F3){ref-type="fig"}C). Importantly, there was more accelerated trans-differentiation of chondrocytes into red bone cells in the cartilage region of CA-β-cat mice than in wild type mice (Figure [3](#F3){ref-type="fig"}, white arrows).

The activation of *β-catenin* in chondrocytes after the initial MCC pattern formation generated a similar phenotype (induced at 2 weeks, harvested at 4 weeks). In X-ray images, the mandibular condyle was more highly mineralized (Figure [4](#F4){ref-type="fig"}A), but the length of condylar process was statistically shorter than normal in the CA-β-cat mice (Figure [S2](#SM0){ref-type="supplementary-material"}B). Back-scattered SEM (Figure [4](#F4){ref-type="fig"}B, central) and acid-etched SEM (Figure [4](#F4){ref-type="fig"}B, lateral) demonstrated that the calcified HC layer in the mutant MCC was thicker with many more HCs than control, which was further confirmed by widespread Col 10 expression in CA-β-cat mice (Figure [S2](#SM0){ref-type="supplementary-material"}C). Goldner staining (Figure [S2](#SM0){ref-type="supplementary-material"}D) also suggested that MCC in CA-β-cat mice was more widely mineralized (indicated by green color).

BrdU positive cells in MCC were significantly increased in CA-β-cat mice (Figure [4](#F4){ref-type="fig"}C). The total thickness of the CA-β-cat MCC was greater than in controls, but with disruptions in the normal cell layering such that HCs were present throughout the depth of the tissue but with much fainter Safranin O staining (Figure [4](#F4){ref-type="fig"}D). IHC against osteopontin (OPN, a marker for early osteogenic cells) demonstrated dramatically expanded OPN expression in the CA-β-cat MCC (Figure [4](#F4){ref-type="fig"}E), indicating a transition to a more osteogenic phenotype.

To further investigate the cellular trans-differentiation, we performed cell lineage tracing, which revealed more and enlarged early chondrocytes in the superficial aspect of the CA-β-cat MCC, indicating an acceleration of chondrogenesis starting from the early stage (Figure [5](#F5){ref-type="fig"}). Co-IHC staining with Col 2 (Figure [5](#F5){ref-type="fig"}A) and Col 10 (Figure [S2](#SM0){ref-type="supplementary-material"}C) demonstrated more discontinuous and patchy immunoreactivity in the CA-β-cat MCC. Strikingly, the flattened chondrocytes and HCs pericellularly expressed high levels of bone markers of Col 1 (Figure [5](#F5){ref-type="fig"}B) and DMP1 (Figure [5](#F5){ref-type="fig"}C), supporting the accelerated trans-differentiation. Interestingly, there were many red cells, which varied in size, that did not express either cartilage or bone markers (Figure [S3](#SM0){ref-type="supplementary-material"}; arrowheads), indicating a lack of cell activity.

By the age of 6 months, the CA-β-cat mice displayed a similar but more severe phenotype. X-ray images showed a short but hypermineralized mandibular condyle in the CA-β-cat mice (Figure [S4](#SM0){ref-type="supplementary-material"}A), and the length of mandible was significantly shorter in the mutant mice (Figure [S4](#SM0){ref-type="supplementary-material"}B). The back scattered SEM image showed a wider condyle with uneven mineralization in the CA-β-cat condylar neck (Figure [S4](#SM0){ref-type="supplementary-material"}C), Both toluidine blue staining (Figure [S4](#SM0){ref-type="supplementary-material"}D) and Col 2 IHC (Figure [S4](#SM0){ref-type="supplementary-material"}E) revealed expanded hypertrophic chondrocytes present throughout the mutant MCC.

In summary, our studies at three different ages demonstrate that constitutive activation of *β-catenin* promotes acceleration of chondrogenesis, osteogenesis and cell trans-differentiation during MCC growth.

Discussion
==========

For many years, chondrogenesis and osteogenesis were thought to be closely linked but separate processes during endochondral bone formation [@B36]. However, the studies from other groups [@B8]-[@B11] and our recent report in long bone challenged this dogma and raised a new hypothesis: chondrogenesis (phase one) and osteogenesis (phase two) are not separate processes but one continuous biological process [@B37]. In this study, our loss- and gain-of-function models of *β-catenin* at different developmental stages demonstrated that *β-catenin* is a key regulator of proliferation and chondrocyte differentiation as well as the direct trans-differentiation of chondrocytes into bone cells during postnatal MCC growth (Figure [5](#F5){ref-type="fig"}D). The deletion of *β-catenin* in aggrecan-secreting cells (Figure [1](#F1){ref-type="fig"}) or HCs (Figure [2](#F2){ref-type="fig"}) produced a similar phenotype: disruptions of chondrogenesis (especially cell differentiation), a sharp reduction in mandibular length, and a drastic reduction in trans-differentiation of chondrocytes into bone cells, as well as bone cell maturation. By contrast, constitutive activation of *β-catenin* in chondrocytes at three ages \[P3 to P7 (Figure [3](#F3){ref-type="fig"}), P14 to 1-month (Figure [4](#F4){ref-type="fig"}-[5](#F5){ref-type="fig"}), and P14 to 6-months (Figure [S4](#SM0){ref-type="supplementary-material"})\] greatly accelerated chondrogenesis, and the trans-differentiation of chondrocytes into bone cells, leading to a shorter but wider condylar neck.

Deletion of *β-catenin* by *Acan*-Cre^ERT2^ affects both cell proliferation and cell differentiation in all chondrocytes, whereas deletion of *β-catenin* by *Col10a1*-Cre mainly induces failure of HCs to trans-differentiate into bone cells, leading to a great accumulation of HCs and pre-hypertrophic chondrocytes. However, both cKO mice models display almost identical subchondral bone phenotypes: a sharp reduction in bone volume, a great decrease in cell trans-differentiation, and a defect in cell maturation (as reflected by bone markers). This finding argues strongly that MCC subchondral bone is mainly formed via cell trans-differentiation from HCs (instead of early chondrocytes) under regulation by*β-catenin,* which is in agreement with previous studies in long bone [@B17], [@B37].

It is well documented that the cKO event is not a complete gene deletion process due to the limitation of Cre efficiency [@B38], which explains why some red bone cells and subchondral bone are still present in cKO mice (Figure [1](#F1){ref-type="fig"}-[2](#F2){ref-type="fig"}). Currently, we do not know why bone markers are largely undetected in the chondrocyte-derived bone cells in both cKO models (i.e., immature bone cells, Figures [1](#F1){ref-type="fig"}-[2](#F2){ref-type="fig"}) as neither Cre line is active in bone cells. We reason that *β-catenin* is not only important for cell trans-differentiation but also critical for bone marker expression even before the cell trans-differentiation event, as we showed that Col 1 and DMP1 are expressed in HCs (Figure [S5](#SM0){ref-type="supplementary-material"}). In other words, osteogenic genes are already activated in HCs. In fact, bone markers expressed in HCs have been reported in the literature [@B39]. Of note, the subchondral bone phenotype is more severe in the Col10a1 cKO mice, which is likely due to its cumulative effects beginning at E14.5 [@B6].

Although the gain of function model supports the role of*β-catenin* in the cell trans-differentiation hypothesis, the mutant ramus length is shorter than controls. We reason that the following two factors are likely responsible for this unexpected phenotype: **a**. the prematurely formed bone cells do not have the full function of mature bone cells, and the existing cartilage matrix may interfere with bone matrix production; **b**. the pattern of MCC ramus is largely formed by the time that *β-catenin* is constitutively activated and the existing bone matrix "blockades" the newly formed bone.

The pronounced changes in MCC gene expression profiles and structure in both mutant cKO models are in agreement with previous studies showing delayed chondrocyte hypertrophy and reduced proliferation in mouse growth plates in which *β-catenin* was deleted in chondrocytes and perichondrial cells [@B18]-[@B20]. The phenotype in the MCC of the CA-β-cat mice is even more striking, presenting a picture of a cartilage transitioning to bone (reduced Safranin O, immunoreactivity for Col 1, osteopontin and DMP1 in the cartilage). This phenotype is similar in some respects to the only other study of the TMJ in mice with constitutively activated *β-catenin*, which reported progressive decreases in Alcian blue and Col 2 staining in 1-6 month-old CA-β-cat mice as well as increased Col 10 staining and greater numbers of hypertrophic chondrocytes that they interpreted as evidence of accelerated chondrocyte hypertrophy [@B25]. Thus, *β-catenin* appears to have a similar regulatory effect on both long bone and TMJ. Currently, our group is searching for other genes that regulate the unique growth of the MCC.
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![**Deletion of *β-catenin* in early chondrocytes led to malformed condylar neck, defective chondrogenesis, and reduced chondrocyte transformation. (A)** X-ray images displayed a lack of calcified cartilage region (yellow dotted line) on mutant mice (arrow in *upper panel*) with a low mineralized condylar ramus (red dotted line) in 2-week old *Acan*-Cre^ERT2^*; β-catenin* cKO mice, and a small condylar head formation (arrows in *middle* and *lower panel*), an expanded ramus neck and a sharp reduction in the ramus length at ages of 4- and 12-weeks. **(B)** Quantitative data of mandibular length revealed a statistically significant reduction of the mandibular length in 12-week old cKO mice (n=4). **(C)** Toluidine blue staining for 2-week old cKO condyles showed a reduction in the metachromatic area of the MCC due to decreased flattened chondrocytes (yellow arrows), and a lack of subchondral bone (white arrow). **(D)** EdU^+^ cells were significantly reduced in proliferating zone of the cKO MCC (n=4). **(E)** Col 2 IHC combined with cell lineage tracing (*Acan*-Cre^ERT2^ was activated at P3, reflecting the initial cell origin in chondrocytes and its transformed bone cells) showed a sharp decrease of Col 2^+^ area in cKO MCC. **(F)** Col 10 IHC demonstrated a dramatic reduction in Col 10-expressing cells in cKO MCC, indicating a defective chondrocyte hypertrophy. **(G)** DMP1 IHC confirmed the dramatic reduction of subchondral bone volume, with less mature osteocytes expressing DMP1 in cKO mice (high magnification in the *lower panel*).](ijbsv14p0001g001){#F1}

![**Deletion of *β*-*catenin* in HCs resulted in diminished endochondral bone formation. (A)** The X-ray images showed an expanded radiolucent area (correlated to the calcified cartilage region, yellow arrow) with an extremely low mineralized ramus in the 2-week old *Col10a1*-Cre; *β-catenin* cKO mice. **(B)** Toluidine blue staining displayed an expansion of all MCC cartilage layers in cKO mice with a particular increase in HCs, but with no trabecular bone present in subchondral bone area. **(C)** Col 2 IHC combined with cell lineage tracing (*Col10a1*-Cre began activation at E14.5, in HCs and their transformed bone cells) demonstrated a considerably thickened Col2^+^ region in cKO mice. **(D)** Col10^+^ cells increased in cKO compared with control mice. **(E-G)** There was only a thin layer of cKO subchondral bone in cKO mice, with a sharp reduction in expression of Runx2 **(E)**, SOST **(F)** and DMP1 **(G)** compared with the control mice (arrows).](ijbsv14p0001g002){#F2}

![**Constitutive activation of *β-catenin* in MCC accelerated chondrogenesis and osteogenesis in early postnatal development. (A)** By using *Acan*-Cre^ERT2^; *β*-catenin*^flox(Ex3)/flox(Ex3)^*mice with Cre activation at P3, we found that Col 2 IHC was more intense in CA-β-cat mice at P7 (arrow). **(B-C)** High level of Col 1 **(B)** and DMP1 **(C)** expression in 7-day CA-β-cat mice indicated the increased osteogenesis in MCC. In addition, there was more accelerated trans-differentiation of chondrocytes into red bone cells in the cartilage region of CA-β-cat mice (arrows).](ijbsv14p0001g003){#F3}

![**Stabilization of *β-catenin* in 4-week old mice enhanced chondrogenesis, promoted chondrocyte proliferation, and affected condylar ramus formation. (A)** X-ray images showed that the CA-β-cat mandibular condyle was highly mineralized with a significantly shorter mandibular length (Cre was activated at 2 weeks, n=4). **(B)** Back-scattered SEM (central) and acid-etched SEM (lateral) demonstrated that the calcified HC layer in the mutant MCC was thicker with many more hypertrophic chondrocytes than control (yellow arrows). **(C)** BrdU^+^ cells in the proliferating zone of mutant mice were significantly increased, indicating higher cell proliferation (n=4). **(D)** Thickness of Safranin O staining was greater in CA-β-cat MCC than in controls, but with disruption of the normal cell layering. **(E)** OPN expression was dramatically expanded in the CA-β-cat MCC, indicating that the ossification of chondrocytes was accelerated.](ijbsv14p0001g004){#F4}

![**Constitutive activation of *β-catenin* led to accelerated cell-transformation from chondrocytes into bone cells, giving rise to osteogenesis in the cartilage. (A)** Co-IHC staining with Col 2 in the CA-β-cat MCC displayed a more widespread, denser, but patchy area of chondrocytes, with many more red prechondroblastic cells (arrow) near the MCC surface. **(B)** Col 1 expression was much higher (arrows) in CA-β-cat MCC (high magnification in *lower panel*). **(C)** Many chondrocytes also expressed high level of DMP1, reflecting the accelerated trans-differentiation from chondrocytes into bone cells in CA-β-cat MCC (arrows). **(D)** Using both conditional deletion and constitutive activation of *β-catenin*, our study demonstrates the critical role of *β-catenin* in the direct trans-differentiation of chondrocytes to bone cells during MCC growth. The lack of *β-catenin* led to a decrease of chondrogenesis and chondrocyte-derived bone cells, accompanied by reduction of subchondral bone volume; the stabilization of*β-catenin* gave rise to more chondrogenesis and cell trans-differentiation, along with cartilage calcification in MCC.](ijbsv14p0001g005){#F5}
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